Marlene Debel insider trades: Metlife (MET) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Marlene reports to the SEC
Open-market buys and sales
5 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Jun 1, 2026 | MET | ↓ Sell | 21,312 | $81.59 | $1.7M | Direct | Jun 3, 2026 (2d) |
| Dec 13, 2024 | MET | ↓ Sell | 22,810 | $82.88 | $1.9M | Direct | Dec 17, 2024 (4d) |
| Aug 9, 2023 | MET | ↓ Sell | 9,391 | $63.18 | $593K | Direct | Aug 11, 2023 (2d) |
| Aug 19, 2022 | MET | ↓ Sell | 4,060 | $67.60 | $274K | Direct | Aug 23, 2022 (4d) |
| May 11, 2021 | MET | ↓ Sell | 11,000 | $64.58 | $710K | Direct | May 12, 2021 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Marlene Debel's insider trades
Marlene Debel is EVP & Chief Risk Officer at Metlife (MET). Since May 11, 2021, Marlene has reported no open-market purchases and 5 sales worth $5.2M on SEC Form 4. In the last 12 months: 1 sale ($1.7M).
Their filings also include grants and awards (15 filings), shares withheld for taxes (14 filings), option exercises (11 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every MET insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.